Drug Discovery
Products Overview
Mechanism of Action (MOA) Prediction Platform
Dataset De-Noising
Clinical Insights
Case Studies
COVID-19
Get Started Now
Blog
About
Company Overview
Products
Our Partners
Leadership
Careers
Let’s Get Started
Contact Us
Case Study
,
Drug Discovery
Poster Presentation: MIT 2020 AI for Drug Discovery Conference
BioSymetrics
/
May 11, 2020
Some of our high level learning was recently presented at the 2020 MIT AI for Drug Discovery conference in February.
Read More
0
0
Search
Recent Posts
BioSymetrics Collaborates with Janssen and Sema4 to Predict the Onset of COVID-19
Drug Repurposing Prediction Using AI and SARS-CoV-2 High-Content Imaging Screening Data
BioSymetrics Joins Accenture’s INTIENT Network
Explore Drug Effects Against SARS-CoV-2 Phenotypic Screening in the Interactive Blog
Predicting Mechanism of Action Using AI – Webinar
Poster Presentation: MIT 2020 AI for Drug Discovery Conference
MOA Prediction Platform to Help With COVID-19 Research
MaRS: How Canadian Startups Are Tackling the COVID-19 Crisis
Archives
Archives
Select Month
August 2020
June 2020
May 2020
April 2020
March 2020
February 2020
January 2020
December 2019
November 2019
October 2019
September 2019
June 2019
May 2019
April 2019
March 2019
February 2019
January 2019
December 2018
November 2018
Drug Discovery
Products Overview
Mechanism of Action (MOA) Prediction Platform
Dataset De-Noising
Clinical Insights
Case Studies
COVID-19
Get Started Now
Blog
About
Company Overview
Products
Our Partners
Leadership
Careers
Let’s Get Started
Contact Us
Send to Email Address
Your Name
Your Email Address
Close
